Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/02/10 20:58:39」(JST)
wiki en
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 成人T細胞性白血病/リンパ腫の治療および予後 treatment and prognosis of adult t cell leukemia lymphoma
- 2. セザリー症候群の治療 treatment of sezary syndrome
English Journal
- Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody.
- Sugata K1,2, Yasunaga J1, Miura M1, Akari H3, Utsunomiya A4, Nosaka K5, Watanabe Y6, Suzushima H6, Koh KR7, Nakagawa M8, Kohara M9, Matsuoka M1.
- Scientific reports.Sci Rep.2016 Jun 2;6:27150. doi: 10.1038/srep27150.
- Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia and inflammatory diseases. Because anti-HTLV-1 immune responses are critical for suppressing infected cells, enhancing cellular immunity is beneficial for the treatment of HTLV-1-associated diseases. Using simian T-cell leukemi
- PMID 27250643
- Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential.
- Duvic M1, Evans M2, Wang C3.
- Therapeutic advances in hematology.Ther Adv Hematol.2016 Jun;7(3):171-4. doi: 10.1177/2040620716636541. Epub 2016 Mar 17.
- Mogamulizumab (KW-0761) is a humanized immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that targets CC chemokine receptor 4 (CCR4). It has shown promising therapeutic potential in phase I and II clinical trials and is currently being investigated for efficacy in treating cutaneous T-cell lymphoma
- PMID 27247757
- Anti-CCR4 Monoclonal Antibody Mogamulizumab Followed by the GDP (Gemcitabine, Dexamethasone and Cisplatin) Regimen in Primary Refractory Angioimmunoblastic T-Cell Lymphoma.
- Kato H1, Yamamoto K, Higuchi Y, Yamamoto H, Saito T, Taji H, Yatabe Y, Nakamura S, Kinoshita T.
- Chemotherapy.Chemotherapy.2016 May 27;62(1):19-22. [Epub ahead of print]
- There are few effective options for salvage therapy in elderly patients with relapsed or refractory angioimmunoblastic T-cell lymphoma (AITL). The anti-CCR4 antibody mogamulizumab works via antibody-dependent cytotoxic activity, reduces regulatory T cells, and evokes antitumor immunity in cancer pat
- PMID 27226129
Japanese Journal
- 成人T細胞性白血病・リンパ腫に対する臍帯血移植の現状と課題
- 血液内科 = Hematology 72(1), 102-107, 2016-01
- NAID 40020729530
- モガムリズマブの新しい展開
- 最新医学 71(1), 126-133, 2016-01
- NAID 40020708354
- 症例 モガムリズマブ治療中の成人T細胞白血病リンパ腫患者に生じたSweet病様皮疹の1例
- 皮膚科の臨床 57(13), 2030-2032, 2015-12
- NAID 40020682494
Related Pictures
★リンクテーブル★
| リンク元 | 「モガムリズマブ」 |
「モガムリズマブ」
- 英
- mogamulizumab
- 商
- ポテリジオ
- 関
- その他の腫瘍用薬